Quantcast

Latest .bd Stories

2010-06-08 07:00:00

FRANKLIN LAKES, N.J., June 8 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has signed agreements to sell certain assets of its BD Medical segment, including the Ophthalmic Systems unit as well as the surgical blades, critical care and extended dwell catheter product platforms of the Medical Surgical Systems unit, to RoundTable Healthcare Partners, an operating-oriented private equity firm...

2010-06-02 10:08:00

BALTIMORE, June 2 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the BD MAX(TM) GBS Assay for Group B Streptococcus (GBS) on the BD MAX(TM) System. The BD MAX System is a next-generation automated workstation for molecular testing designed to streamline workflow and offer full walkaway automation to accommodate varying workloads...

2010-04-08 07:30:00

FRANKLIN LAKES, N.J., April 8 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its second quarter fiscal 2010 earnings conference call on Thursday, April 29, 2010 at 10:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning. The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be...

2010-03-15 08:21:00

FRANKLIN LAKES, N.J., March 15 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that the Company will present at the Barclays Capital 2010 Healthcare Conference on Wednesday, March 24, 2010 at 11:15 a.m. (EDT). The live webcast of BD's presentation can be accessed at the BD corporate website at www.bd.com/investors and will be available for replay through Wednesday, March 31, 2010. BD is a leading global...

2010-02-08 07:30:00

FRANKLIN LAKES, N.J., Feb. 8 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) has voluntarily executed a product recall of certain lots of BD Q-Syte(TM) Luer Access Devices and BD Nexiva(TM) Closed IV Catheter Systems. Use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death. This field corrective action included notification to customers worldwide by letter. Neither the costs anticipated...

2010-01-28 05:00:00

FRANKLIN LAKES, N.J., Jan. 28 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today reported quarterly revenues of $1.917 billion for the first fiscal quarter ended December 31, 2009, representing an increase of 12 percent from the prior-year period, or 9 percent on a foreign currency-neutral basis. "We are pleased with our solid start to fiscal 2010. Our BD Medical and BD Diagnostics segments led our revenue growth, aided by flu-related sales," said Edward J....

2010-01-15 11:29:00

FRANKLIN LAKES, N.J., Jan. 15 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it is donating $550,000 in support of relief efforts to assist the victims of the earthquake in Haiti. A financial donation of $250,000 will be split equally between the American Red Cross and the U.S. Fund for UNICEF. BD will distribute the remainder to AmeriCares, Catholic Medical Mission Board, Direct Relief...

2009-11-20 06:00:00

FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. In May 2009, BD and HandyLab announced an exclusive agreement for BD to develop and commercialize molecular assays on the HandyLab Jaguar(TM) platform, the first fully integrated molecular diagnostic...

2009-11-04 04:00:00

FRANKLIN LAKES, N.J., Nov. 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today reported quarterly revenues of $1.898 billion for the fourth fiscal quarter ended September 30, 2009, representing an increase of 5 percent from the prior-year period, or 8 percent excluding the unfavorable impact from foreign currency translation. For the full fiscal year ended September 30, 2009, BD reported revenues of $7.161 billion, representing an increase of 1 percent over...

2009-10-23 07:00:00

FRANKLIN LAKES, N.J., Oct. 23 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms. The acquisition is subject to regulatory approvals and is expected to close during the first quarter of fiscal year 2010. The financial terms of the agreement were not disclosed....


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related